Engineers Gate Manager LP Novo Cure LTD Transaction History

Engineers Gate Manager LP

$5.55 Billion
Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Novo Cure LTD stock. As of the latest transaction made, Engineers Gate Manager LP holds 254,039 shares of NVCR stock, worth $4.71 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

254,039

Previous 198,933 27.7%

Holding current value

$4.71 Million

Previous $5.93 Million 23.65%

% of portfolio

0.08%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 15, 2025	BUY	$17.82 - $30.19 $981,988 - $1.66 Million	55,106 Added 27.7%	254,039 $4.53 Million
Q4 2024 Feb 14, 2025	SELL	$14.54 - $33.41 $1.51 Million - $3.47 Million	-103,796 Reduced 34.29%	198,933 $5.93 Million
Q3 2024 Nov 14, 2024	BUY	$15.61 - $23.34 $154,008 - $230,272	9,866 Added 3.37%	302,729 $4.73 Million
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $118,607 - $241,125	10,026 Added 3.54%	292,863 $5.02 Million
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $620,167 - $863,341	-49,933 Reduced 15.01%	282,837 $4.42 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $1.74 Million - $2.46 Million	155,982 Added 88.23%	332,770 $4.97 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $1.78 Million - $4.68 Million	110,417 Added 166.36%	176,788 $2.86 Million
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $1.27 Million - $2.6 Million	31,543 Added 90.57%	66,371 $2.75 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $1.97 Million - $4.14 Million	34,828 New	34,828 $2.09 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $181,346 - $288,039	3,204 Added 26.03%	15,512 $1.08 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $3.73 Million - $5.24 Million	-62,002 Reduced 83.44%	12,308 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $4.09 Million - $6.64 Million	54,415 Added 273.51%	74,310 $5.58 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $2.09 Million - $3.51 Million	18,016 Added 958.81%	19,895 $2.31 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $597,492 - $1.03 Million	-4,582 Reduced 70.92%	1,879 $417,000
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $791,325 - $1.21 Million	-6,376 Reduced 49.67%	6,461 $854,000
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $1.9 Million - $2.95 Million	-16,937 Reduced 56.89%	12,837 $2.22 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $603,952 - $1.16 Million	10,404 Added 53.71%	29,774 $3.31 Million
Q2 2020 Aug 17, 2020	SELL	$57.2 - $74.41 $2.16 Million - $2.81 Million	-37,708 Reduced 66.06%	19,370 $1.15 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $2.64 Million - $4.44 Million	46,359 Added 432.49%	57,078 $3.84 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $364,790 - $500,985	5,341 Added 99.31%	10,719 $903,000
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $3.6 Million - $5.68 Million	-58,127 Reduced 91.53%	5,378 $402,000
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $935,637 - $1.4 Million	-22,161 Reduced 25.87%	63,505 $4.02 Million
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $2.74 Million - $4.81 Million	85,666 New	85,666 $4.13 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $154,255 - $282,675	-5,371 Closed	0 $0
Q3 2018 Nov 01, 2018	SELL	$32.0 - $52.4 $1.76 Million - $2.87 Million	-54,849 Reduced 91.08%	5,371 $281,000
Q2 2018 Aug 03, 2018	BUY	$19.85 - $32.0 $1.2 Million - $1.93 Million	60,220 New	60,220 $1.89 Million
Q1 2018 May 07, 2018	SELL	$19.3 - $23.65 $1.31 Million - $1.61 Million	-67,899 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$16.3 - $21.9 $740,639 - $995,092	45,438 Added 202.3%	67,899 $1.37 Million
Q3 2017 Nov 13, 2017	BUY	$18.05 - $21.75 $405,421 - $488,526	22,461	22,461 $446,000

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.95B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Novo Cure LTD Transaction History